DOI QR코드

DOI QR Code

Characterization of Late-Onset Citrullinemia 1 in a Korean Patient: Confirmation by Argininosuccinate Synthetase Gene Mutation Analysis

  • Kim, In-Suk (Department of Laboratory Medicine, Gyeongsang National University School of Medicine) ;
  • Ki, Chang-Seok (Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Jong-Won (Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Mun-Hyang (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jin, Dong-Kyu (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Soo-Youn (Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2006.02.01
  • Accepted : 2006.04.06
  • Published : 2006.07.31

Abstract

A 16-month old boy was referred to our hospital for evaluation of recurrent generalized tonic clonic seizures. Metabolic evaluation revealed significant hyperammonemia ($1,112\;{\mu}g/dl$). Amino acid/acylcarnitine screening using tandem mass spectrometry showed markedly increased plasma levels of citrulline ($1,350\;{\mu}M/l$) with undetectable levels of arginine and arginosuccinic acid. Urinary excretion of citrulline was markedly increased ($38,617\;{\mu}M/g$ creatinine). Brain MRI findings showed diffuse high-signal intensity lesions, that involved gray and white matter in both frontal lobes and insula with edematous changes; these findings were consistent with the acute stage of citrullinemia (CTLN). Mutation analysis of the argininosuccinate synthetase (ASS) gene, in this patient, showed a Gly324Ser mutation in exon 13, and a 67-bp duplication mutation in exon 15 (c.1128-6_1188dup67). The patient was confirmed as having late-onset CTLN1 and treated with anticonvulsants, lactulose enema, protein restricted diet and arginine. Here we describe a case of late-onset CTLN1 in a patient by biochemical analyses and ASS gene mutation confirmation. This is the first report of a Korean patient with late-onset CTLN1 confirmed by ASS gene mutation identification.

Keywords

References

  1. Bachmann, C. (2003a) Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur. J. Pediatr. 162, 29-33 https://doi.org/10.1007/s00431-003-1347-z
  2. Bachmann, C. (2003b) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur. J. Pediatr. 162, 410-416
  3. Gao, H. Z., Kobayashi, K., Tabata, A., Tsuge, H., Iijima, M., Yasuda, T., Kalkanoglu, H. S., Dursun, A., Tokatli, A., Coskun, T., Trefz, F. K., Skladal, D., Mandel, H., Seidel, J., Kodama, S., Shirane, S., Ichida, T., Makino, S., Yoshino, M., Kang, J. H., Mizuguchi, M., Barshop, B. A., Fuchinoue, S., Seneca, S., Zeesman, S., Knerr, I., Rodes, M., Wasant, P., Yoshida, I., De Meirleir, L., Abdul Jalil, M., Begum, L., Horiuchi, M., Katunuma, N., Nakagawa, S. and Saheki, T. (2003) Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients. Hum. Mutat. 22, 24-34 https://doi.org/10.1002/humu.10230
  4. Haberle, J., Pauli, S., Linnebank, M., Kleijer, W. J., Bakker, H. D., Wanders, R. J., Harms, E. and Koch, H. G. (2002) Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. Hum. Genet. 110, 327-333 https://doi.org/10.1007/s00439-002-0686-6
  5. Haberle, J., Pauli, S., Schmidt, E., Schulze-Eilfing, B., Berning, C. and Koch, H. G. (2003) Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol. Genet. Metab. 80, 302-306 https://doi.org/10.1016/j.ymgme.2003.08.002
  6. Hong, K. M., Hahn, S. H. and Paik, M. K. (2000a) Novel 67-bp insertional mutation in the ASS gene in a patient with citrullinemia. Hum. Mutat. 15, 585 https://doi.org/10.1002/1098-1004(200006)15:6<585::AID-HUMU29>3.0.CO;2-C
  7. Hong, K. M., Paik, M. K., Yoo, O. J. and Hahn, S. H. (2000b) The first successful prenatal diagnosis on a Korean family with citrullinemia. Mol. Cells 10, 692-694 https://doi.org/10.1007/s10059-000-0692-2
  8. Hong, K. M., Shin, C. H., Choi, Y. B., Song, W. K., Lee, S. D., Rhee, K. I., Jang, P., Pak, G. S., Kim, J. K., Paik, M. K. and Hahn, S. H. (2000c) Mutation analysis of Korean patients with citrullinemia. Mol. Cells 10, 465-468
  9. Iijima, M., Jalil, A., Begum, L., Yasuda, T., Yamaguchi, N., Xian Li, M., Kawada, N., Endou, H., Kobayashi, K. and Saheki, T. (2001) Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. Adv. Enzyme Regul. 41, 325-342 https://doi.org/10.1016/S0065-2571(00)00022-4
  10. Ikeda, S., Yazaki, M., Takei, Y., Ikegami, T., Hashikura, Y., Kawasaki, S., Iwai, M., Kobayashi, K. and Saheki, T. (2001) Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J. Neurol. Neurosurg. Psychiatry 71, 663-670 https://doi.org/10.1136/jnnp.71.5.663
  11. Jeong, E., Chun, S. and Seo, S. (1999) A case of citrullinemia controlled by diet and arginine. J. Korean Soc. Neonatol. 6, 280-284
  12. Kawamoto, S., Strong, R. W., Kerlin, P., Lynch, S. V., Steadman, C., Kobayashi, K., Nakagawa, S., Matsunami, H., Akatsu, T. and Saheki, T. (1997) Orthotopic liver transplantation for adultonset type II citrullinaemia. Clin. Transplant. 11, 453-458
  13. Kim, B., Bang, H., Lee, D., Lee, S. and Chung, M. (1987) A case of citrullinemia. J. Korean Pediatr. Soc. 30, 794-804
  14. Kim, H., Kim, J., Bae, S., Yoon, C. and Yoo, H. (1999) Two cases of citrullinemia presented with strokes. J. Korean Pediatr. Soc. 42, 437-441
  15. Kobayashi, K., Bang, L. Y., Xian, L. M., Nishi, I., Hsiao, K. J., Choeh, K., Yang, Y., Hwu, W. L., Reichardt, J. K., Palmieri, F., Okano, Y. and Saheki, T. (2003) Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol. Genet. Metab. 80, 356-359 https://doi.org/10.1016/S1096-7192(03)00140-9
  16. Kobayashi, K., Jackson, M. J., Tick, D. B., O'Brien, W. E. and Beaudet, A. L. (1990) Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J. Biol. Chem. 265, 11361-11367
  17. Kobayashi, K., Kakinoki, H., Fukushige, T., Shaheen, N., Terazono, H. and Saheki, T. (1995) Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. Hum. Genet. 96, 454-463
  18. Kobayashi, K., Sinasac, D. S., Iijima, M., Boright, A. P., Begum, L., Lee, J. R., Yasuda, T., Ikeda, S., Hirano, R., Terazono, H., Crackower, M. A., Kondo, I., Tsui, L. C., Scherer, S. W. and Saheki, T. (1999) The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat. Genet. 22, 159-163 https://doi.org/10.1038/9667
  19. Ohura, T., Kobayashi, K., Tazawa, Y., Nishi, I., Abukawa, D., Sakamoto, O., Iinuma, K., and Saheki, T. (2001) Neonatal presentation of adult-onset type II citrullinemia. Hum. Genet. 108, 87-90 https://doi.org/10.1007/s004390000448
  20. Park, B., Lee, D., Choi, J. and Jung, H. (1995) A case of citrullinemia. J. Korean Soc. Neonatol. 2, 248-252
  21. Park, D., Ki, D., Moon, S. and Lee, I. (1997) A case of citrullinemia. J. Korean Pediatr. Soc. 40, 584-592
  22. Park, H., Lim, H., Jung, I., Kim, Y., Kim, I., Chung, I., Kim, H., Park, S., Lee, M., Kim, S. and Lee, D. (2002) A case of adulttype citrullinemia with hyperammonemia. Korean J. Gastroenterol. 39, 379-385
  23. Ruitenbeek, W., Kobayashi, K., Iijima, M., Smeitink, J. A., Engelke, U. F., De Abreu, R. A., Kwast, H. T., Saheki, T., Boelen, C. A., De Jong, J. G. and Wevers, R. A. (2003) Moderate citrullinaemia without hyperammonaemia in a child with mutated and deficient argininosuccinate synthetase. Ann. Clin. Biochem. 40, 102-107 https://doi.org/10.1258/000456303321016259
  24. Saheki, T., Kobayashi, K., Ichiki, H., Matuo, S., Tatsuno, M., Imamura, Y., Inoue, I., Noda, T. and Hagihara, S. (1987) Molecular basis of enzyme abnormalities in urea cycle disorders. With special reference to citrullinemia and argininosuccinic aciduria. Enzyme 38, 227-232 https://doi.org/10.1159/000469209
  25. Song, S., Oh, K., Hong, M., Kim, H., Shin, H., Kim, S. and Chang, J. (2002) A case of citrullinemia diagnosed at the neonatal period. J. Korean Pediatr. Soc. 45, 524-528
  26. Thoene, J., Batshaw, M., Spector, E., Kulovich, S., Brusilow, S., Walser, M. and Nyhan, W. (1977) Neonatal citrllinemia: treatment with keto-analogues of essential amino acids. J. Pediatr. 90, 218-224 https://doi.org/10.1016/S0022-3476(77)80633-1
  27. Whelan, D. T., Brusso, T. and Spate, M. (1976) Citrullinemia: phenotypic variations. Pediatrics 57, 935-941
  28. Wick, H., Bachmann, C., Baumgartner, R., Brechbuhler, T., Colombo, J. P., Wiesmann, U., Mihatsch, M. J. and Ohnacker, H. (1973) Variants of citrullinaemia. Arch. Dis. Child. 48, 636-641 https://doi.org/10.1136/adc.48.8.636
  29. Yun, H. K. L., Lee, D., Kang, S. and Ha, Y. (2003) Screening of newbrons and high risk infants for inherited metabolic disease by tandem mass spectrometry in Korea; 2 Years of the SCL Experience. Korean J. Lab. Med. 23, 517

Cited by

  1. Hyperammonemia-induced toxicity for the developing central nervous system vol.56, pp.1, 2007, https://doi.org/10.1016/j.brainresrev.2007.06.026
  2. Molecular genetics of citrullinemia types I and II vol.431, 2014, https://doi.org/10.1016/j.cca.2014.01.032
  3. Two Hypomorphic Alleles of Mouse Ass1 as a New Animal Model of Citrullinemia Type I and Other Hyperammonemic Syndromes vol.177, pp.4, 2010, https://doi.org/10.2353/ajpath.2010.100118
  4. Current concepts in the pathogenesis of urea cycle disorders vol.100, 2010, https://doi.org/10.1016/j.ymgme.2010.02.010
  5. Mutation spectrum of the ASS1 gene in Korean patients with citrullinemia type I vol.46, pp.3, 2013, https://doi.org/10.1016/j.clinbiochem.2012.10.008
  6. Ammonia toxicity to the brain vol.36, pp.4, 2013, https://doi.org/10.1007/s10545-012-9546-2